Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

BackgroundApproximately 62% of patients with breast cancer with a pathogenic variant (BRCA1 or BRCA2) undergo primary breast-conserving therapy. ObjectiveThe study aims to develop a personalized risk management decision support tool for carriers of a pathogenic va...

Full description

Bibliographic Details
Main Authors:	Jelena Maksimenko, Pedro Pereira Rodrigues, Miki Nakazawa-Miklaševiča, David Pinto, Edvins Miklaševičs, Genadijs Trofimovičs, Jānis Gardovskis, Fatima Cardoso, Maria João Cardoso
Format:	Article
Language:	English
Published:	JMIR Publications 2022-12-01
Series:	JMIR Formative Research
Online Access:	https://formative.jmir.org/2022/12/e37144

Similar Items

Correction: Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study
by: Jelena Maksimenko, et al.
Published: (2023-03-01)

Pregnancy after breast cancer in BRCA1/2 mutation carriers
by: Jelena Maksimenko, et al.
Published: (2022-01-01)

Polygenic Risk Score Predicts Modified Risk in <i>BRCA1</i> Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients
by: Egija Berga-Švītiņa, et al.
Published: (2023-05-01)

Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
by: Emiroglu S, et al.
Published: (2023-02-01)

Outcomes and risk of subsequent breast events in breast‐conserving surgery patients with BRCA1 and BRCA2 mutation
by: Fugui Ye, et al.
Published: (2020-03-01)

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
by: Osman K., et al.
Published: (2022-12-01)

Comparing Prognosis for <i>BRCA1</i>, <i>BRCA2</i>, and Non-BRCA Breast Cancer
by: Pedro Antunes Meireles, et al.
Published: (2023-12-01)

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
by: Li, J, et al.
Published: (2018)

Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
by: Kendra-Ann I. Seenandan-Sookdeo, et al.
Published: (2010-08-01)

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
by: M. M. Tsyganov, et al.
Published: (2020-07-01)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
by: Ellen Warner
Published: (2018-11-01)

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
by: Karin Kast, et al.
Published: (2023-06-01)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
by: Yomali Ferreyra, et al.
Published: (2023-08-01)

Experience in treating BRCA-associated breast cancer. The BRCA-history of a family
by: A. V. Sultanbaev, et al.
Published: (2021-08-01)

BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
by: Yinmei Zhang, et al.
Published: (2024-01-01)

Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer
by: Mohammad Hassan Tajadini, et al.
Published: (2013-02-01)

BRCA1 and BRCA2 Genetic Testing in Breast and/or Ovarian Cancer Families in Iran
by: Fatemeh Keshavarzi, et al.
Published: (2010-01-01)

Role of BRCA 1 и BRCA 2 gene mutations in the occurrence of male breast cancer
by: A. V. Bykova, et al.
Published: (2014-07-01)

The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in <i>BRCA1/BRCA2/PALB2</i>-Negative Women
by: Alexey Larionov, et al.
Published: (2023-01-01)

BRCA1, BRCA2 mutations and the association with the clinicopathological characteristics of women with early-onset breast cancer
by: Ghazali, Mohamad Bazli
Published: (2014)

Molecular profiling of BRCA1 and BRCA2 genes in Turkish patients with early-onset breast cancer
by: Taner Karakaya, et al.
Published: (2023-10-01)

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
by: Taru A. Muranen, et al.
Published: (2023-05-01)

Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants
by: Matteo Lambertini, et al.
Published: (2021-02-01)

Impact of Breast Cancer and Germline BRCA Pathogenic Variants on Fertility Preservation in Young Women
by: Elze Prokurotaite, et al.
Published: (2023-04-01)

Methylation of BRCA1 promoter in sporadic breast cancer
by: Sunil Vitthalrao Jagtap, et al.
Published: (2023-01-01)

<i>BRCA</i> Mutations and Breast Cancer Prevention
by: Joanne Kotsopoulos
Published: (2018-12-01)

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families
by: Kang, P., et al.
Published: (2010)

Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer
by: Haven R. Garber, et al.
Published: (2022-04-01)

Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations
by: Neil M. Iyengar, et al.
Published: (2021-03-01)

Transcriptome Patterns of <i>BRCA1</i>- and <i>BRCA2</i>- Mutated Breast and Ovarian Cancers
by: Arsen Arakelyan, et al.
Published: (2021-01-01)

BRCA2 reversion mutation confers resistance to olaparib in breast cancer
by: Shinya Yamamoto, et al.
Published: (2023-06-01)

Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants – an Asian study of 572 familiesResearch in context
by: Weang-Kee Ho, et al.
Published: (2024-03-01)

Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience
by: Joon Young Hur, et al.
Published: (2020-05-01)

Predominance of <i>BRCA2</i> Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with <i>BRCA1</i> or <i>BRCA2</i> Mutation
by: Pascal Pujol, et al.
Published: (2022-07-01)

53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers.
by: Bouwman, P, et al.
Published: (2010)

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.
by: Cox, D, et al.
Published: (2011)

The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis
by: Katie Lin, et al.
Published: (2022-06-01)

Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness
by: Lars v. B. Andersen, et al.
Published: (2023-06-01)

Retarding breast tumor growth with nanoparticle-facilitated intravenous delivery of BRCA1 and BRCA2 tumor suppressor genes
by: Nabilah Ibnat, et al.
Published: (2023-01-01)

Pathogenic <i>APC</i> Variants in Latvian Familial Adenomatous Polyposis Patients
by: Zanda Daneberga, et al.
Published: (2019-09-01)